Recommendations for Benchmarking Preclinical Studies of Nanomedicines
about
Contrast agents for molecular photoacoustic imaging.A facile route to core-shell nanoparticulate formation of arsenic trioxide for effective solid tumor treatment.Quantitative Evaluation of the Enhanced Permeability and Retention (EPR) Effect.Tumor accumulation of liposomal doxorubicin in three murine models: Optimizing delivery efficiency.Magnetic targeting of paclitaxel-loaded poly(lactic--glycolic acid)-based nanoparticles for the treatment of glioblastomaMinimum information reporting in bio-nano experimental literature
P2860
Recommendations for Benchmarking Preclinical Studies of Nanomedicines
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Recommendations for Benchmarking Preclinical Studies of Nanomedicines
@ast
Recommendations for Benchmarking Preclinical Studies of Nanomedicines
@en
type
label
Recommendations for Benchmarking Preclinical Studies of Nanomedicines
@ast
Recommendations for Benchmarking Preclinical Studies of Nanomedicines
@en
prefLabel
Recommendations for Benchmarking Preclinical Studies of Nanomedicines
@ast
Recommendations for Benchmarking Preclinical Studies of Nanomedicines
@en
P2860
P1433
P1476
Recommendations for Benchmarking Preclinical Studies of Nanomedicines
@en
P2093
Charlene M Dawidczyk
P2860
P304
P356
10.1158/0008-5472.CAN-15-1558
P407
P577
2015-08-06T00:00:00Z